Mirae Asset Global Investments Co. Ltd. Buys 4,107 Shares of Zoetis Inc. (NYSE:ZTS)

Mirae Asset Global Investments Co. Ltd. boosted its holdings in Zoetis Inc. (NYSE:ZTS) by 6.7% during the 4th quarter, Holdings Channel reports. The firm owned 65,760 shares of the company’s stock after acquiring an additional 4,107 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Zoetis were worth $10,753,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in ZTS. Darwin Wealth Management LLC bought a new position in Zoetis in the 3rd quarter worth about $31,000. First Personal Financial Services purchased a new stake in Zoetis in the 3rd quarter worth approximately $33,000. Capital Performance Advisors LLP purchased a new position in shares of Zoetis in the 3rd quarter valued at approximately $33,000. Dunhill Financial LLC lifted its stake in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares during the period. Finally, Fortitude Family Office LLC increased its position in Zoetis by 1,387.5% during the 3rd quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock valued at $46,000 after buying an additional 222 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

ZTS has been the subject of several research analyst reports. Morgan Stanley cut their price objective on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a report on Wednesday, January 29th. Stifel Nicolaus decreased their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Leerink Partners initiated coverage on Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective on the stock. UBS Group initiated coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target for the company. Finally, JPMorgan Chase & Co. upped their target price on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $215.00.

Zoetis Stock Performance

NYSE:ZTS opened at $174.07 on Friday. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53. The firm has a market capitalization of $78.54 billion, a price-to-earnings ratio of 32.72, a PEG ratio of 2.72 and a beta of 0.90. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The firm’s fifty day simple moving average is $169.39 and its 200 day simple moving average is $179.32.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.36 EPS. As a group, equities research analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. This is an increase from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date is Tuesday, January 21st. Zoetis’s payout ratio is presently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.